Figure 4From: Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™ Mitotically inactivated ValloVax™ retains activity against B16 melanoma growth. Female C57BL/6 mice (10 mice per group) were immunized with saline, ValloVax™, ValloVax™ lysate, formalin fixed ValloVax™, or irradiated Vallovax™ at a concentration of 5 × 10(5) cells or cell equivalents on days 0, 7, 14, and 21. Tumor growth was initiated by subcutaneous administration of 5 × 10(5) B16 cells and quantified every third day.Back to article page